This announcement is a separate document:
華領醫藥-B：自願性公告 - 就第二代葡萄糖激酶異位激活劑向FDA提交新藥臨床試驗申請並獲受理
HUA MEDICINE-B: VOLUNTARY ANNOUNCEMENT - IND APPLICATION OF 2nd GENERATION GLUCOKINASE ALLOSTERIC ACTIVATOR FILED WITH AND ACCEPTED BY FDA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.